NF-??B ACTIVATION HAS TISSUE-SPECIFIC EFFECTS ON IMMUNE CELL APOPTOSIS DURING POLYMICROBIAL SEPSIS
- 1 October 2002
- journal article
- basic science-aspects
- Published by Wolters Kluwer Health in Shock
- Vol. 18 (4) , 380-386
- https://doi.org/10.1097/00024382-200210000-00015
Abstract
Studies indicate that critically ill patients who succumb to sequela of sepsis/multiorgan failure, as well as septic animals, exhibit an apparently pathological increase in apoptosis (Ao) in the immune system. However, the mechanisms regulating these changes are unclear. Studies also indicate that, dependent on the cell population and the nature and/or duration of the stimuli, activation of the nuclear factor (NF)-κB can either suppress or enhance Ao. Thus, the aim of this study was to determine the contribution of NF-κB activation to the onset of Ao seen in divergent immune cell populations during sepsis, as produced by cecal ligation and puncture (CLP). To assess this, C3H/HeN mice were pretreated (for 1 h) subcutaneously with either 100 mg/kg body weight of pyrrolidine dithiocarbamate (PDTC), an NF-κB inhibitor, or with saline vehicle, prior to subjecting them to CLP or Sham-CLP (Sham). Thymocytes, phagocytes, and Peyer's Patch cells were harvested 24 h later, and the extent of Ao was determined by flow cytometry. The results indicate that PDTC pretreatment had no marked effect on the increase in thymocyte or phagocyte Ao seen following CLP, but there was a significant decline in the extent of Ao observed in septic mouse Peyer's patch B cells. To the extent that this was a result of NF-κB inhibition, we demonstrate by Western analysis, electrophoretic mobility shift assay (EMSA) and transfactor assay that the translocation of c-Rel to septic mouse Peyer's patch B cell nuclei is attenuated by PDTC. PDTC pretreatment also markedly reduced the number of Peyer's patch B cells that were producing IgA as well as attenuated the increase of proinflammatory cytokines in the blood. Interestingly, PDTC pretreatment did not restore peritoneal macrophage function or improve animal survival. Taken together, the inability of PDTC pretreatment to alter the Ao response of thymocytes or phagocytes, while inhibiting the increase in Peyer's patch B cell Ao in septic mice, implies not only that the activation of NF-κB has highly tissue/cell-specific effects that must be discerned when trying to clarify the pathophysiological role of NF-κB in sepsis, but that the activation of NF-κB may contribute to the early adaptive responses required by the host to fend off septic challenge.Keywords
This publication has 30 references indexed in Scilit:
- What is the role of interleukin 10 in polymicrobial sepsis: Anti-inflammatory agent or immunosuppressant?Surgery, 1999
- NF-κB Antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to Suppress Caspase-8 ActivationScience, 1998
- TRANSCRIPTIONAL REGULATION DURING B CELL DEVELOPMENTAnnual Review of Immunology, 1998
- ANIMAL MODELS OF SEPSIS AND SHOCKShock, 1998
- Intestinal mucosal permeability to 51Cr-ethylenediaminetetraacetic acid is increased after bilateral lower extremity ischemia-reperfusion in the ratSurgery, 1996
- THE NF-κB AND IκB PROTEINS: New Discoveries and InsightsAnnual Review of Immunology, 1996
- Function and Activation of NF-kappaB in the Immune SystemAnnual Review of Immunology, 1994
- Programmed cell death, apoptosis and killer genesImmunology Today, 1993
- Effect of hemorrhagic shock on bacterial translocation, intestinal morphology, and intestinal permeability in conventional and antibiotic-decontaminated ratsCritical Care Medicine, 1990
- Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism.The Journal of Experimental Medicine, 1990